RxDoctor Payments DataLook up a doctor →

Pablo Banderas

Medical · Cape Coral, FLNPI 1609868835

Payments from drug & device makers

$27,082in general payments, 2019–2025

Across 1,135 payments — averaging $23.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Amgen$2K
  • AbbVie$2K
  • GSK$1K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$1K
  • plus $15K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca73$2,729
Amgen109$2,408
AbbVie(2 entities)95$2,345
GSK74$1,466
Johnson & Johnson37$1,348
Lilly USA, LLC58$1,346
Novo Nordisk68$1,244
Bayer38$1,239
Biohaven Pharmaceutical Holding Company Ltd.20$1,153
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)44$1,038
Pfizer56$1,033
Merck40$847
Novartis46$794
Esperion Therapeutics, Inc.21$552
Sumitomo Pharma America, Inc.25$548
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$500
Antares Pharma, Inc.25$492
Sanofi-aventis U.S. LLC20$466
Amarin Pharma, Inc.23$449
Sunovion Pharmaceuticals Inc.20$404
Otsuka America Pharmaceutical, Inc.18$366
Astellas Pharma US Inc12$314
Axsome Therapeutics, Inc.9$309
Boehringer Ingelheim14$258
Corcept Therapeutics12$254
Biohaven Pharmaceuticals, Inc.9$242
Optinose US, Inc.7$228
Lundbeck LLC14$226
Takeda Pharmaceuticals U.S.A., Inc.12$222
Phathom Pharmaceuticals, Inc.8$219
Kowa Pharmaceuticals America, Inc.14$199
Regeneron Healthcare Solutions, Inc.2$161
Radius Health, Inc.8$154
Philips North America LLC6$140
Teva Pharmaceuticals USA, Inc.7$129
Corium, LLC5$115
Clarus Therapeutics Inc.8$112
Xeris Pharmaceuticals, Inc.5$109
Halozyme Inc5$88
Eisai Inc.4$86
Avanir Pharmaceuticals, Inc.4$84
Dexcom, Inc.4$77
Idorsia Pharmaceuticals US Inc4$70
Abbott3$61
Jazz Pharmaceuticals Inc.4$58
Azurity Pharmaceuticals, Inc.2$45
Currax Pharmaceuticals LLC2$31
Paratek Pharmaceuticals, Inc.2$29
Acerus Pharmaceuticals Corporation2$26
E.r. Squibb & Sons, L.L.C.1$26
Scilex Pharmaceuticals Inc.1$25
Grifols USA, LLC1$24
Stryker1$23
Lexicon Pharmaceuticals, Inc.1$23
Boston Scientific1$21
Biogen1$21
Daiichi Sankyo Inc.1$19
Amryt Pharma Holdings Ltd1$19
Redhill Biopharma Inc.1$17
Adlon Therapeutics L.p.1$15

How this compares

$27,082 in reported general payments places this provider in the 95th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$50,847
Medicare patients
161
Services billed
2,038

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Cape Coral

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →